CP
MRTX

Castleview Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Castleview Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$226 – 724
2022
Q4 		$226 Buy
+5
New +$226 ﹤0.01% 613